Curry, N., Albayrak, C., Escobar, M., Andre Holme, P., Kearney, S., Klamroth, R., . . . Lentz, S. R. (2019). Once‐weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8‐GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial). Haemophilia.
Styl cytowania ChicagoCurry, Nicola, et al. "Once‐weekly Prophylaxis With GlycoPEGylated Recombinant Factor VIII (N8‐GP) in Severe Haemophilia A: Safety and Efficacy Results From Pathfinder 2 (randomized Phase III Trial)." Haemophilia 2019.
Styl cytowania MLACurry, Nicola, et al. "Once‐weekly Prophylaxis With GlycoPEGylated Recombinant Factor VIII (N8‐GP) in Severe Haemophilia A: Safety and Efficacy Results From Pathfinder 2 (randomized Phase III Trial)." Haemophilia 2019.